Here we demonstrate that AUY954 selectively inhibits proliferation in fibroblasts from COPD patients compared to normal lung fibroblasts, suggesting that the anti-fibrotic and anti-inflammatory effects of ECP may be partially mediated by S1P and that S1P downregulation might be one of the key mechanisms of ECP. Here, MBTPS1 is linked to chronic obstructive pulmonary disease.